Home LiteratureArticle Details
PMID: 15915461 Published · ppublish English Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S. Validation Study

Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Hepatology (Baltimore, Md.) ·Vol. 41 ·No. 6 ·2005-06-00 ·Pages 1313-21

Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Nonalcoholic Steatohepatitis Clinical Research Network

Abstract

Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis in the absence of a history of significant alcohol use or other known liver disease. Nonalcoholic steatohepatitis (NASH) is the progressive form of NAFLD. The Pathology Committee of the NASH Clinical Research Network designed and validated a histological feature scoring system that addresses the full spectrum of lesions of NAFLD and proposed a NAFLD activity score (NAS) for use in clinical trials. The scoring system comprised 14 histological features, 4 of which were evaluated semi-quantitatively: steatosis (0-3), lobular inflammation (0-2), hepatocellular ballooning (0-2), and fibrosis (0-4). Another nine features were recorded as present or absent. An anonymized study set of 50 cases (32 from adult hepatology services, 18 from pediatric hepatology services) was assembled, coded, and circulated. For the validation study, agreement on scoring and a diagnostic categorization ("NASH," "borderline," or "not NASH") were evaluated by using weighted kappa statistics. Inter-rater agreement on adult cases was: 0.84 for fibrosis, 0.79 for steatosis, 0.56 for injury, and 0.45 for lobular inflammation. Agreement on diagnostic category was 0.61. Using multiple logistic regression, five features were independently associated with the diagnosis of NASH in adult biopsies: steatosis (P = .009), hepatocellular ballooning (P = .0001), lobular inflammation (P = .0001), fibrosis (P = .0001), and the absence of lipogranulomas (P = .001). The proposed NAS is the unweighted sum of steatosis, lobular inflammation, and hepatocellular ballooning scores. In conclusion, we present a strong scoring system and NAS for NAFLD and NASH with reasonable inter-rater reproducibility that should be useful for studies of both adults and children with any degree of NAFLD. NAS of > or =5 correlated with a diagnosis of NASH, and biopsies with scores of less than 3 were diagnosed as "not NASH."

MeSH Terms
Adult Child Fatty Liver/pathology Fibrosis Humans Inflammation/pathology Liver/pathology Logistic Models Observer Variation Severity of Illness Index
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Kleiner David E
Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA. [email protected]
Brunt Elizabeth M
Van Natta Mark
Behling Cynthia
Contos Melissa J
Cummings Oscar W
Ferrell Linda D
Liu Yao-Chang
Torbenson Michael S
Unalp-Arida Aynur
Yeh Matthew
McCullough Arthur J
Sanyal Arun J
Nonalcoholic Steatohepatitis Clinical Research Network
Article Info
Journal
Hepatology (Baltimore, Md.)
Abbr.
Hepatology
ISSN
0270-9139
Published
2005-06-00
Pages
1313-21
Language
English
Region
United States
NLM ID
8302946
Subset
IM
Grants
NHLBI NIH HHS · N01HR761019 · United States
NIDDK NIH HHS · 1U01DK061728 · United States
NIDDK NIH HHS · 5U01DK061730 · United States
NIDDK NIH HHS · U01 DK061730 · United States
NIDDK NIH HHS · 1U01DK061738 · United States
NIDDK NIH HHS · 1U01DK061734 · United States
NIDDK NIH HHS · 1U01DK061731 · United States
NIDDK NIH HHS · 7U01DK061713 · United States
NIDDK NIH HHS · 1U01DK061737 · United States
NIDDK NIH HHS · U01 DK061732 · United States
NIDDK NIH HHS · 1U01DK061718 · United States
NIDDK NIH HHS · 1U01DK061732 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]